Literature DB >> 10328922

Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation.

M Dodig1, T Tadic, M S Kronenberg, S Dacic, Y H Liu, R Maxson, D W Rowe, A C Lichtler.   

Abstract

Msx2 is believed to play a role in regulating bone development, particularly in sutures of cranial bone. In this study we investigated the effects of retroviral-mediated overexpression of Msx2 mRNA, in both sense and antisense orientations, on primary cultured chick calvarial osteoblasts. Unregulated overexpression of sense mRNA produced high levels of Msx2 protein throughout the culture period, preventing the expected fall as the cells differentiate. The continued high expression of Msx2 prevented osteoblastic differentiation and mineralization of the extracellular matrix. In contrast, expression of antisense Msx2 RNA decreased proliferation and accelerated differentiation. In other studies, we showed that the Msx2 promoter was widely expressed during the proliferative phase of mouse calvarial osteoblast cultures but was preferentially downregulated in osteoblastic nodules. These results support a model in which Msx2 prevents differentiation and stimulates proliferation of cells at the extreme ends of the osteogenic fronts of the calvariae, facilitating expansion of the skull and closure of the suture. Copyright 1999 Academic Press.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1999        PMID: 10328922     DOI: 10.1006/dbio.1999.9258

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  27 in total

Review 1.  Derivation of the mammalian skull vault.

Authors:  G M Morriss-Kay
Journal:  J Anat       Date:  2001 Jul-Aug       Impact factor: 2.610

Review 2.  Combinatorial transcriptional interaction within the cardiac neural crest: a pair of HANDs in heart formation.

Authors:  Anthony B Firulli; Simon J Conway
Journal:  Birth Defects Res C Embryo Today       Date:  2004-06

3.  Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in low-density culture.

Authors:  D S Yoon; Y H Kim; H S Jung; S Paik; J W Lee
Journal:  Cell Prolif       Date:  2011-10       Impact factor: 6.831

4.  MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma.

Authors:  Y Zhai; A Iura; S Yeasmin; A B Wiese; R Wu; Y Feng; E R Fearon; K R Cho
Journal:  Oncogene       Date:  2011-04-18       Impact factor: 9.867

Review 5.  Mechanical influences on suture development and patency.

Authors:  Susan W Herring
Journal:  Front Oral Biol       Date:  2008

Review 6.  Transcriptional control of mesenchymal stem cell differentiation.

Authors:  Jess Frith; Paul Genever
Journal:  Transfus Med Hemother       Date:  2008-05-08       Impact factor: 3.747

Review 7.  Cranial sutures: a multidisciplinary review.

Authors:  Antonio Di Ieva; Emiliano Bruner; Jennilee Davidson; Patrizia Pisano; Thomas Haider; Scellig S Stone; Michael D Cusimano; Manfred Tschabitscher; Fabio Grizzi
Journal:  Childs Nerv Syst       Date:  2013-03-08       Impact factor: 1.475

8.  Effects of bone morphogenetic protein-2 and transforming growth factor beta1 on gene expression of transcription factors, AJ18 and Runx2 in cultured osteoblastic cells.

Authors:  Minoru Takagi; Naoko Kamiya; Tomihisa Takahashi; Shinsuke Ito; Mitsuharu Hasegawa; Naoto Suzuki; Koji Nakanishi
Journal:  J Mol Histol       Date:  2004-01       Impact factor: 2.611

9.  Up-regulation of MSX2 enhances the malignant phenotype and is associated with twist 1 expression in human pancreatic cancer cells.

Authors:  Kennichi Satoh; Shin Hamada; Kenji Kimura; Atsushi Kanno; Morihisa Hirota; Jun Umino; Wataru Fujibuchi; Atsushi Masamune; Naoki Tanaka; Koh Miura; Shinichi Egawa; Fuyuhiko Motoi; Michiaki Unno; Barbara K Vonderhaar; Tooru Shimosegawa
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

Review 10.  Transcriptional regulatory cascades in Runx2-dependent bone development.

Authors:  Tong Ming Liu; Eng Hin Lee
Journal:  Tissue Eng Part B Rev       Date:  2012-12-28       Impact factor: 6.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.